Trastornos del movimiento

A genetic analysis of a Spanish population with early onset Parkinson's disease

Analysis of p.Tyr307Asn variant in the LRP10 gene in Parkinson's disease in southern Spain

Association of PET-based stages of amyloid deposition with neuropathological markers of A beta pathology

Association ofPICALMwith Cognitive Impairment in Parkinson's Disease

Delineating the motor phenotype of SGCE-myoclonus dystonia syndrome

Disentangling Heterogeneity in Alzheimer's Disease and Related Dementias Using Data-Driven Methods

Growth Differentiation Factor 15 is a potential biomarker of therapeutic response for TK2 deficient myopathy

Impaired motor cortical plasticity associated with cannabis use disorder in young adults

Impairment of Everyday Spatial Navigation Abilities in Mild Cognitive Impairment Is Weakly Associated with Reduced Grey Matter Volume in the Medial Part of the Entorhinal Cortex

In vivo staging of regional amyloid deposition predicts functional conversion in the preclinical and prodromal phases of Alzheimer ?s disease

Integrating genetic and clinical data to predict impulse control disorders in Parkinson's disease (1)

Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease

Longitudinal validity ofPET-based staging of regional amyloid deposition

Mood in Parkinson's disease: From early- to late-stage disease

Mutational spectrum of GNAL, THAP1 and TOR1A genes in isolated dystonia: study in a population from Spain and systematic literature review

Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease

Non-motor symptom burden in patients with Parkinson's disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort (1)

Non-motor symptom burden is strongly correlated to motor complications in patients with Parkinson's disease

Optimized clinical management of Parkinson's disease with opicapone. Recommendations from Spanish experts

Pedunculopontine Nucleus Microstructure Predicts Postural and Gait Symptoms in Parkinson's Disease

Quality of life and non-motor symptoms in Parkinson's disease patients with subthreshold depression

Short-afferent inhibition and cognitive impairment in Parkinson's disease: A quantitative review and challenges (1)

Sleep Problems Are Related to a Worse Quality of Life and a Greater Non-Motor Symptoms Burden in Parkinson's Disease

Targeted Next-Generation Sequencing in a Large Cohort of Genetically Undiagnosed Patients with Neuromuscular Disorders in Spain

The impact of freezing of gait on functional dependency in Parkinson's disease with regard to motor phenotype

Time Course of Recovery From Resistance Exercise With Different Set Configurations

Trastornos de tics e impulso premonitorio: validacion de la version espanola de la Escala para el Impulso Premonitorio al Tic en ninos y adolescentes

Velocity-based resistance training: impact of velocity loss in the set on neuromuscular performance and hormonal response

A replication study of GWAS-genetic risk variants associated with Parkinson's disease in a Spanish population.

Abnormal cerebellar connectivity and plasticity in isolated cervical dystonia.

Acute lower limb paresis in a patient with rheumatoid arthritis: Emergency neuroimaging findings.

Antibodies to neuronal surface proteins in Tourette Syndrome: Lack of evidence in a European paediatric cohort.

Applications of the European Parkinson's Disease Association sponsored Parkinson's Disease Composite Scale (PDCS).

Biological or mechanical prostheses for isolated aortic valve replacement in patients aged 50-65 years: the ANDALVALVE study.

COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation.

Chronic adult-onset of growth hormone/IGF-I hypersecretion improves cognitive functions and LTP and promotes neuronal differentiation in adult rats.

Clinical and genetic characteristics of late-onset Huntington's disease.

Deoxynucleoside Therapy for Thymidine Kinase 2-Deficient Myopathy.

Diagnostic and therapeutic guidelines for polymedicated or with systemic comorbidities patient with movement disorder

Diagnostic protocol of hereditary ataxias and hereditary spastic paraplegia

Diagnostic protocol of tremor

Enhanced Motivational Modulation of Motor Behaviour with Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease.

European Multicentre Tics in Children Studies (EMTICS): protocol for two cohort studies to assess risk factors for tic onset and exacerbation in children and adolescents.

Extensive validation study of the Parkinson's Disease Composite Scale.

Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson's disease

Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project.

High ultrasensitive serum C-reactive protein may be related to freezing of gait in Parkinson's disease patients.

Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome wide association studies

Identification of symbol digit modality test score extremes in Huntington's disease.

Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation.

Increased bilirubin levels in Parkinson's disease.

Mitochondria function associated genes contribute to Parkinson's Disease risk and later age at onset.

Movement disorders. Etiology. Classification. Chorea syndromes and dystonia

Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson's disease heritability.

NOVEL intronic CAPN3 Roma mutation alters splicing causing RNA mediated decay.

Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort.

Other movement disorders: tics and Tourette syndrome, tremor, myoclonus and restless legs syndrome

PLA2G6-associated neurodegeneration: New insights into brain abnormalities and disease progression.

Parkinson's disease and other parkinsonisms: diagnostic protocol

Parkinson's disease and parkinsonism

Quantitative Intensity Harmonization of Dopamine Transporter SPECT Images Using Gamma Mixture Models.

Raising serum urate levels in Parkinson disease: A strategy only for women?

Role of ANO3 mutations in dystonia: A large-scale mutational screening study.

SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease.

Stimulus Sensitive Foot Myoclonus: A Clue to Coeliac Disease.

Síndromes atáxicos. Ataxias heredodegenerativas

The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight.

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer's Disease in APOE ε4 Non-carriers.

The Premonitory Urge for Tics Scale in a large sample of children and adolescents: psychometric properties in a developmental context. An EMTICS study.

The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease

Therapeutic protocol for Parkinson's disease

Using global team science to identify genetic Parkinson's disease worldwide

Varón de 58 años con parkinsonismo, disartria y mioclonías

Analysis of shared heritability in common disorders of the brain.

Automatic and voluntary motor inhibition: Intact processes for tic suppression?

Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37.

Consensus on the diagnosis, treatment and follow-up of patients with Duchenne muscular dystrophy.

Continuous intestinal infusion of levodopa-carbidopa in patients with advanced Parkinson's disease in Spain: Subanalysis by autonomous community.

De novo sequence and copy number variants are strongly associated with Tourette disorder and implicate cell polarity in pathogenesis

Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.

In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.

Investigation of previously implicated genetic variants in chronic tic disorders: a transmission disequilibrium test approach.

LRP10 in α-synucleinopathies.

Obatoclax and Paclitaxel Synergistically Induce Apoptosis and Overcome Paclitaxel Resistance in Urothelial Cancer Cells

Retrospective natural history of thymidine kinase 2 deficiency.

Short-afferent inhibition and cognitive impairment in Parkinson's disease: A quantitative review and challenges.

Spanish expert consensus on the use of safinamide in Parkinson's disease.

TMEM230 in Parkinson's disease in a southern Spanish population.

Teaching Video NeuroImages: The signs of dystonic tremor: Tremulous "escanciador"

The Complex Role of Store Operated Calcium Entry Pathways and Related Proteins in the Function of Cardiac, Skeletal and Vascular Smooth Muscle Cells.

Validation of a simple screening tool for early diagnosis of advanced Parkinson's disease in daily practice: the CDEPA questionnaire

[Bilateral Wallerian degeneration of pontocerebellar fibres secondary to pontine infarction].

[Cryptogenic West syndrome: Clinical profile, response to treatment and prognostic factors].

[Myths and evidence on the use of botulinum toxin: neuropharmacology and dystonia].

A Bayesian spatial model for neuroimaging data based on biologically informed basis functions.

Abnormal sensorimotor integration correlates with cognitive profile in vascular parkinsonism.

Assessment of plasma chitotriosidase activity, CCL18/PARC concentration and NP-C suspicion index in the diagnosis of Niemann-Pick disease type C: a prospective observational study

Clinical rating scale for pantothenate kinase-associated neurodegeneration: A pilot study.

Consensus on the Definition of Advanced Parkinson's Disease: A Neurologists-Based Delphi Study (CEPA Study).

Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher Disease.

Genetic analysis of CHCHD2 in a southern Spanish population.

Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's disease.

Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype.

N370S-GBA1 mutation causes lysosomal cholesterol accumulation in Parkinson's disease.

Parkinson's Disease Severity at 3 Years Can Be Predicted from Non-Motor Symptoms at Baseline.

Screening study of TUBB4A in isolated dystonia.

Tremor stability index: a new tool for differential diagnosis in tremor syndromes.

Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease

Informe de la Fundación del Cerebro sobre el impacto social de la enfermedad de Parkinson en Espana.

S1761R mutation is not a common cause of Parkinson's disease in Spain.

Dificultades en la toma de decisiones en la fase final de la vida de un niño con atrofia muscular espinal.

Algoritmo de tratamiento de la enfermedad de Parkinson inicial.

Electromiografía en el estudio de trastornos del movimiento. (1)

Fisiopatología de la enfermedad de Parkinson.

Trastornos hipercinéticos en el anciano.